Ozempic blindness isn’t a real diagnosis. It’s a nickname used to describe sudden vision loss that may be linked to the weight loss drugs semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, ...

The diabetes drugs Ozempic and Wegovy have been linked to an increased risk of sudden vision loss and blindness due to a rare eye condition known as NAION (non-arteritic anterior ischemic optic ...

SOUTH CAROLINA (WCIV) — Before the COVID-19 pandemic, more than 13 million Americans were living with low or no vision. Vision loss rates continue to soar five years later. "There's very little ...

Share on Pinterest Research on GLP-1 drugs and eye health has been inconsistent, but experts say the risk of serious eye disease is generally low. Getty Images/Hiraman Studies have linked GLP-1 ...

The phrase “eye stroke” has recently appeared in news reports about a very rare side-effect of weight-loss injections. It’s not a formal medical diagnosis, but a shorthand used to describe a condition ...

Have you noticed how many people are turning to new medicines to help lose weight? These drugs, like Ozempic and Wegovy, have become very popular. But what if they come with risks that affect ...

India’s growing burden of avoidable blindness is emerging as a major public health concern. Despite significant advancements in ophthalmology and access to modern diagnostic technologies, awareness ...

A small percentage of patients on injectable weight loss drugs such as Ozempic and Wegovy experienced permanent vision loss, according to a new study. The report, published Thursday in the medical ...

Minutes from the township’s April 30 meeting say Fire Chief Greg Lang was told to turn in his keys, laptop, car, and phone. Federal lawsuit filed against CMHA; property manager arrested for rent theft ...

FRANKLIN, Ind. — When Elizabeth Wilde Gestner woke up one morning in September 2024, something wasn’t right. She could not see out of most of her right eye. There was no warning. No physical pain.

Patients who were prescribed Ozempic (semaglutide), Wegovy (semaglutide), Mounjaro (tirzepatide), or other GLP-1 receptor agonist medications to treat type 2 diabetes or for weight loss may be at risk ...